BlackRock Inc. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 1 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$299,000
-24.5%
867,8090.0%0.00%
Q4 2021$396,000
-34.8%
867,8090.0%0.00%
Q3 2021$607,000
-5.7%
867,8090.0%0.00%
Q2 2021$644,000
-40.3%
867,809
-20.1%
0.00%
Q1 2021$1,079,000
+107800.0%
1,085,509
+162889.3%
0.00%
Q4 2020$1,0000.0%6660.0%0.00%
Q3 2020$1,0000.0%6660.0%0.00%
Q2 2020$1,0000.0%6660.0%0.00%
Q1 2020$1,0006660.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2022
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders